September 17, 2024
Trending Now
1
Trial Shows 0.01% Atropine Appears Effective and Safe in Myopia and Exotropia Management
2
Virtual Reality Treatment for Amblyopia Shows Clinically Meaningful Vision Improvement
3
Optometrists' Insights on Hyperopia Prescribing Patterns and Practices
4
Myopia Surge: 740 Million Youth Affected by 2050
5
New NASEM Report Calls for Enhanced Myopia Surveillance and Early Vision Screening
6
Lifestyle Habits Tied to Myopia Development
Conference Coverage
Association for Research in Vision and Ophthalmology annual meeting
Clinical Guidelines
View MoreNovember 01, 2023
EDITORS PERSPECTIVE
November 01, 2023
What's New
September 01, 2023
Satisfy the Needs of Plano Presbyopes
September 01, 2023
BUSINESS Legal
Commentary & Perspectives
View MoreSeptember 24, 2024
Clobetasol Soon to be Available in the US
FDA & Government News
View MoreSeptember 24, 2024
SKG1108 Receives FDA Orphan Drug Designation
September 24, 2024
EDVI Act Supports More Comprehensive Eye Care for Children
September 23, 2024
MCO-010 Advances to Phase 3 for Stargardt Macular Degeneration
August 27, 2024
PCPs Play Important Role in Glaucoma Screening
Business Management
View MoreSeptember 01, 2024
Optometric Business Tracker
September 01, 2024
The EB Optical Checklist
August 30, 2024